Physician profile
Jonathan N Hamilton
NPI 1609965508
$223,930.87
in general payments reported to CMS, 2019-2025
40 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,671 · 2021: $47K · 2022: $41K · 2023: $57K · 2024: $37K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $94K · Food and Beverage: $7,350 · Honoraria: $5,950 · Travel and Lodging: $5,462 · Consulting Fee: $2,000 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $94,267.56 |
| Food and Beverage | $7,350.47 |
| Honoraria | $5,950.00 |
| Travel and Lodging | $5,461.54 |
| Consulting Fee | $2,000.00 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $190,906.24 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $18,344.56 | 2019-2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $6,484.66 | 2020-2025 | Prolaris, Myrisk, Bracanalysis Cdx |
| Pfizer INC. | $2,036.37 | 2020-2025 | |
| Janssen Biotech, INC. | $759.07 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Janssen Global Services, LLC | $500.00 | 2025 | |
| Olympus America INC. | $482.61 | 2019-2025 | Itind System, Soltive, Uretero-Reno Videoscope |
| Boston Scientific Corporation | $470.45 | 2019-2025 | Ams 700, Lithovue, Moses 550 Dfl |
| Axonics, INC. | $409.37 | 2021-2024 | Axonics |
| Abbvie INC. | $404.49 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $379.33 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $374.58 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Coloplast Corp | $357.29 | 2019-2022 | |
| Baxter Healthcare | $251.10 | 2020-2025 | Floseal |
| Endo Pharmaceuticals INC. | $247.69 | 2019-2024 | Xiaflex |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $202.17 | 2021-2024 | |
| Endo USA, INC. | $181.15 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $159.16 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $155.24 | 2024-2025 | Aquabeam System |
| Urogen Pharma, INC. | $110.74 | 2021-2024 | Jelmyto |
| Sumitomo Pharma America, INC. | $103.21 | 2023-2025 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $101.01 | 2023-2025 | Lynparza |
| Urovant Sciences INC | $89.73 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $65.66 | 2022-2025 | |
| Myovant Sciences INC. | $63.79 | 2021-2022 | |
| Neotract INC. | $54.40 | 2019 | |
| Palette Life Sciences, INC. | $36.26 | 2022 | |
| Allergan, INC. | $23.98 | 2019-2020 | |
| Mimedx Group, INC. | $22.83 | 2025 | |
| Progenics Pharmaceuticals, INC. | $22.14 | 2025 | |
| Ethicon US, LLC | $21.31 | 2024 | Surgicel Nu-Knit |
| Lsi Solutions INC | $20.44 | 2024 | Jnw Urtrac |
| Angiodynamics, INC. | $16.93 | 2024 | Nanoknife |
| Tolmar, INC. | $16.44 | 2025 | Jatenzo, Eligard |
| Integra Lifesciences Corporation | $15.80 | 2025 | Tenoglide |
| Laborie Medical Technologies Corp. | $15.58 | 2025 | |
| Amgen INC. | $14.04 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.05 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.